Cargando…
The importance of the granulocyte-colony stimulating factor in oncology
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common effects with granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5). G-CSF is mainly produced by fibroblasts and endothelial cells from bone marrow s...
Autores principales: | CETEAN, SÎNZIANA, CĂINAP, CĂLIN, CONSTANTIN, ANNE-MARIE, CĂINAP, SIMONA, GHERMAN, ALEXANDRA, OPREAN, LUMINIŢA, HANGAN, ADRIANA, OPREAN, RADU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689238/ https://www.ncbi.nlm.nih.gov/pubmed/26732055 http://dx.doi.org/10.15386/cjmed-531 |
Ejemplares similares
-
Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab
por: GHERMAN, ALEXANDRA, et al.
Publicado: (2017) -
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
por: Căinap, Călin, et al.
Publicado: (2021) -
Classic tumor markers in gastric cancer. Current standards and limitations
por: CĂINAP, CĂLIN, et al.
Publicado: (2015) -
Metallo-Drugs in Cancer Therapy: Past, Present and Future
por: Lucaciu, Roxana Liana, et al.
Publicado: (2022) -
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer
por: Gherman, Alexandra, et al.
Publicado: (2023)